Literature DB >> 16873723

Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 mitogen-activated protein kinase in the heart.

Olli Tenhunen1, Jaana Rysä, Mika Ilves, Ylermi Soini, Heikki Ruskoaho, Hanna Leskinen.   

Abstract

Mitogen-activated protein kinases (MAPKs) regulate cardiomyocyte growth and apoptosis in response to extracellular stimulation, but the downstream effectors that mediate their pathophysiological effects remain poorly understood. We determined the targets and role of p38 MAPK in the heart in vivo by using local adenovirus-mediated gene transfer of constitutively active upstream kinase mitogen-activated protein kinase kinase 3b (MKK3bE) and wild-type p38alpha in rats. DNA microarray analysis of animals with cardiac-specific overexpression of p38 MAPK revealed that 264 genes were upregulated more than 2-fold including multiple genes controlling cell division, cell signaling, inflammation, adhesion, and transcription. A large number of previously unknown p38 target genes were found. Using gel mobility-shift assays we identified several cardiac transcription factors that were directly activated by p38 MAPK. Finally, we determined the functional significance of the altered cardiac gene-expression profile by histological analysis and echocardiographic measurements, which indicated that p38 MAPK overexpression-induced gene expression results in myocardial cell proliferation, inflammation, and fibrosis. In conclusion, we defined the novel target genes and transcription factors as well as the functional effects of p38 MAPK in the heart. Expression profiling of p38 MAPK overexpression identified cell cycle regulatory and inflammatory genes critical for pathological processes in the adult heart.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873723     DOI: 10.1161/01.RES.0000238387.85144.92

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  27 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 2.  Mitogen-activated protein kinases in heart development and diseases.

Authors:  Yibin Wang
Journal:  Circulation       Date:  2007-09-18       Impact factor: 29.690

3.  Characterization of a novel MK3 splice variant from murine ventricular myocardium.

Authors:  Nadège Moïse; Dharmendra Dingar; Aida M Mamarbachi; Louis R Villeneuve; Nada Farhat; Matthias Gaestel; Maya Khairallah; Bruce G Allen
Journal:  Cell Signal       Date:  2010-06-04       Impact factor: 4.315

4.  Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice.

Authors:  Daniel J Conklin; Petra Haberzettl; Ganapathy Jagatheesan; Shahid Baba; Michael L Merchant; Russell A Prough; Jessica D Williams; Sumanth D Prabhu; Aruni Bhatnagar
Journal:  Toxicol Appl Pharmacol       Date:  2015-04-10       Impact factor: 4.219

5.  Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice.

Authors:  Laura J Sommerville; Sheri E Kelemen; Michael V Autieri
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-08       Impact factor: 8.311

6.  Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarction.

Authors:  Elza D van Deel; Zhongbing Lu; Xin Xu; Guangshuo Zhu; Xinli Hu; Tim D Oury; Robert J Bache; Dirk J Duncker; Yingjie Chen
Journal:  Free Radic Biol Med       Date:  2007-12-15       Impact factor: 7.376

7.  p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia.

Authors:  Huiqiu Yin; Jidong Zhang; Haiqing Lin; Rong Wang; Yun Qiao; Bo Wang; Fenye Liu
Journal:  Inflammation       Date:  2007-10-18       Impact factor: 4.092

8.  Inhibition of allograft inflammatory factor-1 expression reduces development of neointimal hyperplasia and p38 kinase activity.

Authors:  Laura J Sommerville; Chen Xing; Sheri E Kelemen; Satoru Eguchi; Michael V Autieri
Journal:  Cardiovasc Res       Date:  2008-09-08       Impact factor: 10.787

9.  Engineered early embryonic cardiac tissue increases cardiomyocyte proliferation by cyclic mechanical stretch via p38-MAP kinase phosphorylation.

Authors:  Kelly C Clause; Joseph P Tinney; Li J Liu; Bradley B Keller; Kimimasa Tobita
Journal:  Tissue Eng Part A       Date:  2009-06       Impact factor: 3.845

10.  Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat.

Authors:  Erik Vahtola; Marjut Louhelainen; Hanna Forstén; Saara Merasto; Johanna Raivio; Petri Kaheinen; Ville Kytö; Ilkka Tikkanen; Jouko Levijoki; Eero Mervaala
Journal:  Cardiovasc Diabetol       Date:  2010-01-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.